Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer That Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?

出版年份 2010 全文链接

标题

作者

关键词

出版物

Volume 20, Issue 7, Pages 1125-1131

出版商

Wiley

发表日期

2010-12-04

DOI

10.1111/igc.0b013e3181efd843

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started